434 related articles for article (PubMed ID: 23616148)
1. Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma.
Reiners C; Biko J; Haenscheid H; Hebestreit H; Kirinjuk S; Baranowski O; Marlowe RJ; Demidchik E; Drozd V; Demidchik Y
J Clin Endocrinol Metab; 2013 Jul; 98(7):3039-48. PubMed ID: 23616148
[TBL] [Abstract][Full Text] [Related]
2. Thyroid cancer in infants and adolescents after Chernobyl.
Reiners C; Demidchik YE; Drozd VM; Biko J
Minerva Endocrinol; 2008 Dec; 33(4):381-95. PubMed ID: 18923372
[TBL] [Abstract][Full Text] [Related]
3. Bone mineral density in treated at a young age for differentiated thyroid cancer after Chernobyl female patients on TSH-suppressive therapy receiving or not Calcium-D3 supplementation.
Leonova TA; Drozd VM; Saenko VA; Mine M; Biko J; Rogounovitch TI; Takamura N; Reiners C; Yamashita S
Endocr J; 2015; 62(2):173-82. PubMed ID: 25374130
[TBL] [Abstract][Full Text] [Related]
4. Patients with differentiated thyroid cancer who underwent radioiodine thyroid remnant ablation with low-activity ¹³¹I after either recombinant human TSH or thyroid hormone therapy withdrawal showed the same outcome after a 10-year follow-up.
Molinaro E; Giani C; Agate L; Biagini A; Pieruzzi L; Bianchi F; Brozzi F; Ceccarelli C; Viola D; Piaggi P; Vitti P; Pacini F; Elisei R
J Clin Endocrinol Metab; 2013 Jul; 98(7):2693-700. PubMed ID: 23626005
[TBL] [Abstract][Full Text] [Related]
5. Success of the postoperative 131I therapy in young Belarusian patients with differentiated thyroid cancer after Chernobyl depends on the radiation absorbed dose to the blood and the thyroglobulin level.
Hänscheid H; Verburg FA; Biko J; Diessl S; Demidchik YE; Drozd V; Reiners C
Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1296-302. PubMed ID: 21461735
[TBL] [Abstract][Full Text] [Related]
6. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Jarzab B; Handkiewicz-Junak D; Wloch J
Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
[TBL] [Abstract][Full Text] [Related]
7. I-131 activities as high as safely administrable (AHASA) for the treatment of children and adolescents with advanced differentiated thyroid cancer.
Verburg FA; Biko J; Diessl S; Demidchik Y; Drozd V; Rivkees SA; Reiners C; Hänscheid H
J Clin Endocrinol Metab; 2011 Aug; 96(8):E1268-71. PubMed ID: 21613356
[TBL] [Abstract][Full Text] [Related]
8. Autoimmune thyroiditis and exposure to iodine 131 in the Ukrainian cohort study of thyroid cancer and other thyroid diseases after the Chornobyl accident: results from the first screening cycle (1998-2000).
Tronko MD; Brenner AV; Olijnyk VA; Robbins J; Epstein OV; McConnell RJ; Bogdanova TI; Fink DJ; Likhtarev IA; Lubin JH; Markov VV; Bouville AC; Terekhova GM; Zablotska LB; Shpak VM; Brill AB; Tereshchenko VP; Masnyk IJ; Ron E; Hatch M; Howe GR
J Clin Endocrinol Metab; 2006 Nov; 91(11):4344-51. PubMed ID: 16912122
[TBL] [Abstract][Full Text] [Related]
9. Outcome after high-dose radioiodine therapy for advanced differentiated thyroid carcinoma in childhood.
Gao YC; Lu HK
Endocr Res; 2009; 34(4):121-9. PubMed ID: 19878072
[TBL] [Abstract][Full Text] [Related]
10. Favourable course of disease after incomplete remission on (131)I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up.
Biko J; Reiners C; Kreissl MC; Verburg FA; Demidchik Y; Drozd V
Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):651-5. PubMed ID: 21113590
[TBL] [Abstract][Full Text] [Related]
11. Short-term effectiveness of low-dose radioiodune ablative treatment of thyroid remnants after thyroidectomy for differentiated thyroid cancer.
Vermiglio F; Violi MA; Finocchiaro MD; Baldari S; Castagna MG; Moleti M; Mattina F; Pio Lo Presti V; Bonanno N; Trimarchi F
Thyroid; 1999 Apr; 9(4):387-91. PubMed ID: 10319946
[TBL] [Abstract][Full Text] [Related]
12. "High-dose" radioiodine therapy in advanced differentiated thyroid carcinoma.
Menzel C; Grünwald F; Schomburg A; Palmedo H; Bender H; Späth G; Biersack HJ
J Nucl Med; 1996 Sep; 37(9):1496-503. PubMed ID: 8790201
[TBL] [Abstract][Full Text] [Related]
13. Clinical presentation and clinical outcomes in Chernobyl-related paediatric thyroid cancers: what do we know now? What can we expect in the future?
Tuttle RM; Vaisman F; Tronko MD
Clin Oncol (R Coll Radiol); 2011 May; 23(4):268-75. PubMed ID: 21324656
[TBL] [Abstract][Full Text] [Related]
14. Post-Chernobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France.
Pacini F; Vorontsova T; Demidchik EP; Molinaro E; Agate L; Romei C; Shavrova E; Cherstvoy ED; Ivashkevitch Y; Kuchinskaya E; Schlumberger M; Ronga G; Filesi M; Pinchera A
J Clin Endocrinol Metab; 1997 Nov; 82(11):3563-9. PubMed ID: 9360507
[TBL] [Abstract][Full Text] [Related]
15. Analysis of thyroid malignant pathologic findings identified during 3 rounds of screening (1997-2008) of a cohort of children and adolescents from belarus exposed to radioiodines after the Chernobyl accident.
Zablotska LB; Nadyrov EA; Rozhko AV; Gong Z; Polyanskaya ON; McConnell RJ; O'Kane P; Brenner AV; Little MP; Ostroumova E; Bouville A; Drozdovitch V; Minenko V; Demidchik Y; Nerovnya A; Yauseyenka V; Savasteeva I; Nikonovich S; Mabuchi K; Hatch M
Cancer; 2015 Feb; 121(3):457-66. PubMed ID: 25351557
[TBL] [Abstract][Full Text] [Related]
16. Treatment of thyroid carcinoma after the Chernobyl power plant accident: a difficult balancing act.
Reiners C; Biko J; Leonova T; Drozd V
Lancet; 2020 Mar; 395(10229):e61. PubMed ID: 32222199
[No Abstract] [Full Text] [Related]
17. Low but measurable stimulated serum thyroglobulin levels <2 µg/L frequently predict incomplete response in differentiated thyroid cancer patients.
Aldawish M; Jha N; McEwan AJ; Severin D; Ghosh S; Morrish DW
Endocr Res; 2014; 39(4):157-63. PubMed ID: 24460082
[TBL] [Abstract][Full Text] [Related]
18. Is diagnostic iodine-131 scanning with recombinant human TSH useful in the follow-up of differentiated thyroid cancer after thyroid ablation?
Mazzaferri EL; Kloos RT
J Clin Endocrinol Metab; 2002 Apr; 87(4):1490-8. PubMed ID: 11932270
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors.
Song HJ; Qiu ZL; Shen CT; Wei WJ; Luo QY
Eur J Endocrinol; 2015 Sep; 173(3):399-408. PubMed ID: 26104753
[TBL] [Abstract][Full Text] [Related]
20. Risk of thyroid cancer after exposure to 131I in childhood.
Cardis E; Kesminiene A; Ivanov V; Malakhova I; Shibata Y; Khrouch V; Drozdovitch V; Maceika E; Zvonova I; Vlassov O; Bouville A; Goulko G; Hoshi M; Abrosimov A; Anoshko J; Astakhova L; Chekin S; Demidchik E; Galanti R; Ito M; Korobova E; Lushnikov E; Maksioutov M; Masyakin V; Nerovnia A; Parshin V; Parshkov E; Piliptsevich N; Pinchera A; Polyakov S; Shabeka N; Suonio E; Tenet V; Tsyb A; Yamashita S; Williams D
J Natl Cancer Inst; 2005 May; 97(10):724-32. PubMed ID: 15900042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
